Fremont, CA, United States of America

Rhoneil L Pena

This inventor holds 1 USPTO granted patent. Top assignee: Nektar Therapeutics. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rhoneil L Pena. Retrieved from https://idiyas.com/inventor/rhoneil-l-pena

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment: The Contributions of Rhoneil L Pena

Introduction

Rhoneil L Pena, an inventive mind based in Fremont, CA, has made significant strides in the field of cancer immunotherapy. His innovative approaches to treating cancer have the potential to improve the lives of many patients battling this formidable disease.

Latest Patents

Rhoneil holds a patent for an "Immunotherapeutic tumor treatment method." This groundbreaking invention involves administering a toll-like receptor 7/8 (TLR7/8) agonist in combination with a long-acting IL-2Rβ-biased agonist and a programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) axis inhibitor. The patent outlines methods, compositions, dosage forms, and kits related to this novel cancer treatment, showcasing Rhoneil's contributions to advancing therapeutic options for cancer patients.

Career Highlights

Currently, Rhoneil is employed at Nektar Therapeutics, a biopharmaceutical company focused on developing innovative therapies for cancer and other diseases. His work at Nektar Therapeutics has positioned him at the forefront of research and development in cancer treatment, highlighting his dedication to improving healthcare outcomes through innovation.

Collaborations

Throughout his career, Rhoneil has collaborated with notable colleagues, including Jonathan Zalevsky and Neel Kumar Anand. These partnerships reflect a commitment to fostering teamwork and sharing knowledge, which are essential elements for driving advancements in the field of immunotherapy.

Conclusion

Rhoneil L Pena's contributions to cancer treatment through his patent for an immunotherapeutic tumor treatment method exemplify the transformative power of innovation in medicine. His work at Nektar Therapeutics, in collaboration with esteemed colleagues, underscores the importance of collaboration in the quest for more effective cancer therapies. As science continues to evolve, Rhoneil's efforts pave the way for a brighter future in cancer care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…